Cigna Corporation (CI) Stock Analysis
Is CI a good investment?
Cigna Corporation (CI) has a Plutrex AI rating of 72.5/100 as of May 26, 2026, indicating a Buy consensus. The stock is not classified as halal-compliant. Key strength: Massive valuation discount with PE 60.3% below industry average (12.13 vs 30.58) despite solid fundamentals. Main concern: Forward EPS growth of 10.0% significantly underperforms industry average of 45.35% by 78%, indicating competitive disadvantage.
Investment Summary
CI presents a compelling value opportunity with exceptional profitability metrics and attractive valuation despite growth concerns. ROE of 15.3% commands a 259% premium over industry average of 4.25%, while trading at massive 60.3% discount to industry PE (12.13 vs 30.58). PEG ratio of 1.14 indicates reasonable valuation given 10.0% forward EPS growth. Strong cash generation of $6.9 billion free cash flow and $7.85 billion cash position provide financial flexibility. However, forward EPS growth of 10.0% significantly trails industry average of 45.35% by 78%, creating competitive disadvantage.
Key Strengths
- Massive valuation discount with PE 60.3% below industry average (12.13 vs 30.58) despite solid fundamentals
- Superior profitability with ROE of 15.3% commanding 259% premium over industry average
- Exceptional cash generation with $6.9 billion free cash flow and $7.85 billion cash position
Key Concerns
- Forward EPS growth of 10.0% significantly underperforms industry average of 45.35% by 78%, indicating competitive disadvantage
- Thin operating margin of 5.5% and low net margin of 2.3% suggest operational efficiency challenges
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
CI demonstrates mixed fundamentals with exceptional cash generation but margin pressures. Operating margin of 5.5% is thin for healthcare sector, while net margin of 2.3% is concerningly low. However, ROE of 15.3% shows effective equity utilization. Debt-to-equity of 0.70 indicates moderate leverage. Free cash flow of $6.9 billion is exceptional, demonstrating strong cash conversion. Forward growth of 10.0% next year and 7.5% five-year provides reasonable expansion, though trailing industry peers significantly. PEG ratio of 1.14 suggests fair valuation given growth prospects. Additional metrics: PE Ratio: 12.13
News Sentiment
Cigna and the broader health insurance sector are experiencing a remarkable turnaround as medical costs ease significantly across the industry. Recent headlines highlight 'U.S. Health Insurers Raise EPS Estimates After Strong Q1'26' as companies consistently beat earnings expectations, with medical costs coming in lower than anticipated. This industry-wide trend suggests systemic factors are benefiting the entire health insurance sector, not just individual company performance. Analysts are noting that 'Easing medical costs a positive for health insurers' while acknowledging that 'a real test lies ahead.' For Cigna specifically, the company is 'Marching To Full Recovery' with strong performance in both profit and revenue indicating effective operational execution. However, experts caution that while 'Major health insurers show signs of recovery,' a key test looms as the industry faces ongoing regulatory and competitive pressures. The positive momentum reflects improved cost management and operational efficiency across the sector.
Risk Assessment
Primary risks include sustained growth underperformance versus peers and potential margin compression in competitive healthcare market. Planned Obamacare exit affecting 369,000 members creates revenue headwind. However, strong balance sheet and cash generation provide downside protection.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is CI a halal stock?
No, Cigna Corporation (CI) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for CI?
Cigna Corporation (CI) has a Plutrex AI rating of 72.5/100 with a Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is CI a good investment?
According to Plutrex AI, CI has a Buy rating (72.5/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in CI?
US stocks like CI can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in CI?
Plutrex AI identifies the main risks for CI by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.